» Authors » Daniel Blockmans

Daniel Blockmans

Explore the profile of Daniel Blockmans including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 144
Citations 3511
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Blockmans D
Rheumatology (Oxford) . 2025 Mar; 64(Supplement_1):i55-i58. PMID: 40071419
In this article, the author explains the relationship between GCA and PMR, based on historical studies, his own experience with a large group of patients and recent publications. Searching for...
2.
Ponte C, Schmidt W, Blockmans D
Rheumatology (Oxford) . 2025 Mar; 64(Supplement_1):i123-i125. PMID: 40071407
The breakout session "Imaging in Disease Assessment" featured six abstracts on imaging advancements for vasculitis. Disease extent on cranial MRI and its association with visual complications in giant cell arteritis...
3.
Moreel L, Doumen M, Betrains A, De Langhe E, Blockmans D, Vanderschueren S
Semin Arthritis Rheum . 2025 Mar; 72:152695. PMID: 40022967
Objective: To validate the polymyalgia rheumatica-activity score (PMR-AS). Methods: Prospective cohort study at the University Hospitals Leuven (Belgium) between July 2022 and December 2023. We created a new alternative PMR-AS...
4.
Moreel L, Betrains A, Boeckxstaens L, Pieters G, Wuyts E, Weynand B, et al.
Eur J Nucl Med Mol Imaging . 2025 Feb; PMID: 40000462
Purpose: To evaluate the diagnostic accuracy of PET/CT, cranial MRI, ultrasound and temporal artery biopsy (TAB) in patients with suspected giant cell arteritis (GCA) in a direct comparison. Methods: Consecutive...
5.
Delaisse N, Blockmans D, Van Ginderdeuren R, Missotten G
Case Rep Ophthalmol . 2025 Feb; 16(1):102-106. PMID: 39981540
Introduction: Immunoglobulin G4-related disease (IgG4-RD) is a systemic, immune-mediated disorder marked by the infiltration of IgG4-positive plasma cells and fibrosis in affected organs. This report presents a rare case of...
6.
Moreel L, Betrains A, Boeckxstaens L, Molenberghs G, Van Laere K, De Langhe E, et al.
Rheumatology (Oxford) . 2024 Aug; PMID: 39173669
Objectives: To evaluate differences in presentation and outcome of giant cell arteritis (GCA) patients with and without large vessel vasculitis (LVV) and according to the extent and severity of LVV....
7.
Moreel L, Betrains A, Boeckxstaens L, Molenberghs G, Van Laere K, De Langhe E, et al.
Semin Arthritis Rheum . 2024 Jul; 68:152499. PMID: 38968729
Objectives: To evaluate differences in presentation and outcome of giant cell arteritis (GCA) patients with and without polymyalgia rheumatica (PMR) symptoms. Methods: Consecutive patients diagnosed with GCA between 2000 and...
8.
Moreel L, Betrains A, De Langhe E, Vanderschueren S, Blockmans D
Rheumatology (Oxford) . 2024 May; 63(12):e325-e327. PMID: 38759111
No abstract available.
9.
Borrego-Yaniz G, Ortiz-Fernandez L, Madrid-Paredes A, Kerick M, Hernandez-Rodriguez J, Mackie S, et al.
Lancet Rheumatol . 2024 May; 6(6):e374-e383. PMID: 38734017
Background: Giant cell arteritis is an age-related vasculitis that mainly affects the aorta and its branches in individuals aged 50 years and older. Current options for diagnosis and treatment are...
10.
Moreel L, Betrains A, De Langhe E, Blockmans D, Vanderschueren S
Eur J Intern Med . 2024 Apr; 126:134-136. PMID: 38688812
No abstract available.